Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples, Oral Fluid Samples), By Drug (Alcohol, Cannabis/Marijuana, Cocaine), By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within Immediate
Drug Testing Market Growth & Trends
The global drug testing market size is expected t%li%reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc.. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated t%li%foster market growth during the forecast period.
Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests t%li%prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products t%li%meet this growing demand.
For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance t%li%market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing t%li%help courts & government agencies t%li%monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.
Continuous government initiatives and implementation of strict substance abuse testing regulations t%li%ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power t%li%conduct random roadside drug testing of drivers t%li%reduce impaired driving in the country. The new bill allows usage of oral fluid tests t%li%check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis t%li%ensure safe air travel.
Drug Testing Market Report Highlights
Drug Testing Market Growth & Trends
The global drug testing market size is expected t%li%reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc.. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated t%li%foster market growth during the forecast period.
Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests t%li%prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products t%li%meet this growing demand.
For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance t%li%market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing t%li%help courts & government agencies t%li%monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.
Continuous government initiatives and implementation of strict substance abuse testing regulations t%li%ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power t%li%conduct random roadside drug testing of drivers t%li%reduce impaired driving in the country. The new bill allows usage of oral fluid tests t%li%check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis t%li%ensure safe air travel.
Drug Testing Market Report Highlights
- By product type, the consumables segment dominated the market in 2023, owing t%li%its repetitive use t%li%conduct substance abuse screening
- Based on sample type, the urine samples segment accounted for the largest revenue share in 2023, as it is the most common method of sample collection
- Increased unemployment and economic crisis due t%li%the Covid-19 pandemic has made people more susceptible t%li%substance abuse, thus created lucrative opportunities in the market
- The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated t%li%change the current scenari%li%and may create demand for innovative testing solutions
- Stringent privacy rights in some countries are likely t%li%limit substance abuse testing at workplaces, impeding market growth
- In Asia Pacific, the market is expected t%li%witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Sample
1.2.3. Drug
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Sample outlook
2.2.3. Drug outlook
2.2.4. End Use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
CHAPTER 3. DRUG TESTING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High prevalence of substance abuse
3.2.1.2. Stringent laws mandating alcohol and drug testing
3.2.1.3. Increasing government initiatives to monitor substance abuse
3.2.2. Market restraint analysis
3.2.2.1. Drug testing is considered a violation of privacy rights in some countries
3.3. Drug Testing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. DRUG TESTING MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Drug Testing Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Consumables
4.4.1.1. Consumables Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Instruments
4.4.2.1. Instruments Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rapid Testing Devices
4.4.3.1. Rapid Testing Devices Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Services
4.4.4.1. Services Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. DRUG TESTING MARKET: SAMPLE ESTIMATES & TREND ANALYSIS
5.1. Sample Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Drug Testing Market by Sample Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Urine Samples
5.4.1.1. Urine Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Oral Fluid Samples
5.4.2.1. Oral Fluid Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hair Samples
5.4.3.1. Hair Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Other Samples
5.4.4.1. Other Samples Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. DRUG TESTING MARKET: DRUG TYPE ESTIMATES & TREND ANALYSIS
6.1. Drug Type Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Drug Testing Market by Drug type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Alcohol
6.4.1.1. Alcohol Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Cannabis/Marijuana
6.4.2.1. Cannabis/Marijuana Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Cocaine
6.4.3.1. Cocaine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Opioids
6.4.4.1. Opioids market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Amphetamine & Methamphetamine
6.4.5.1. Amphetamine & Methamphetamine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. LSD
6.4.6.1. LSD Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others
6.4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. DRUG TESTING MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. End Use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Drug Testing Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Drug Testing Laboratories
7.4.1.1. Drug Testing Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Workplaces
7.4.2.1. Workplaces Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Hospitals
7.4.3.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Others
7.4.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. DRUG TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America: SWOT Analysis
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. Europe: SWOT Analysis
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework
8.6.9.3. Competitive scenario
8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific: SWOT Analysis
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Latin America: SWOT Analysis
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Mexico
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Argentina
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. MEA: SWOT Analysis
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario
8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Quest Diagnostics Incorporated
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Services benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Abbott
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Services benchmarking
9.3.5.4. Strategic initiatives
9.3.6. F. Hoffmann-La Roche Ltd.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Services benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Quidel Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Services benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Thermo Fisher Scientific, Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Services benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Siemens Healthcare GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Services benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Bio-Rad Laboratories, Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Services benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Agilent Technologies, Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Services benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Laboratory Corporation of America Holdings
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Services benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Clinical Reference Laboratory, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Services benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Cordant Health Solutions
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Services benchmarking
9.3.14.4. Strategic initiatives
CHAPTER 10. CONCLUSION
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Sample
1.2.3. Drug
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Sample outlook
2.2.3. Drug outlook
2.2.4. End Use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
CHAPTER 3. DRUG TESTING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High prevalence of substance abuse
3.2.1.2. Stringent laws mandating alcohol and drug testing
3.2.1.3. Increasing government initiatives to monitor substance abuse
3.2.2. Market restraint analysis
3.2.2.1. Drug testing is considered a violation of privacy rights in some countries
3.3. Drug Testing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. DRUG TESTING MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Drug Testing Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Consumables
4.4.1.1. Consumables Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Instruments
4.4.2.1. Instruments Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rapid Testing Devices
4.4.3.1. Rapid Testing Devices Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Services
4.4.4.1. Services Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. DRUG TESTING MARKET: SAMPLE ESTIMATES & TREND ANALYSIS
5.1. Sample Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Drug Testing Market by Sample Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Urine Samples
5.4.1.1. Urine Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Oral Fluid Samples
5.4.2.1. Oral Fluid Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hair Samples
5.4.3.1. Hair Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Other Samples
5.4.4.1. Other Samples Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. DRUG TESTING MARKET: DRUG TYPE ESTIMATES & TREND ANALYSIS
6.1. Drug Type Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Drug Testing Market by Drug type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Alcohol
6.4.1.1. Alcohol Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Cannabis/Marijuana
6.4.2.1. Cannabis/Marijuana Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Cocaine
6.4.3.1. Cocaine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Opioids
6.4.4.1. Opioids market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Amphetamine & Methamphetamine
6.4.5.1. Amphetamine & Methamphetamine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. LSD
6.4.6.1. LSD Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others
6.4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. DRUG TESTING MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. End Use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Drug Testing Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Drug Testing Laboratories
7.4.1.1. Drug Testing Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Workplaces
7.4.2.1. Workplaces Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Hospitals
7.4.3.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Others
7.4.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. DRUG TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America: SWOT Analysis
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. Europe: SWOT Analysis
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework
8.6.9.3. Competitive scenario
8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific: SWOT Analysis
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Latin America: SWOT Analysis
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Mexico
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Argentina
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. MEA: SWOT Analysis
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario
8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Quest Diagnostics Incorporated
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Services benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Abbott
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Services benchmarking
9.3.5.4. Strategic initiatives
9.3.6. F. Hoffmann-La Roche Ltd.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Services benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Quidel Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Services benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Thermo Fisher Scientific, Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Services benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Siemens Healthcare GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Services benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Bio-Rad Laboratories, Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Services benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Agilent Technologies, Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Services benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Laboratory Corporation of America Holdings
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Services benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Clinical Reference Laboratory, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Services benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Cordant Health Solutions
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Services benchmarking
9.3.14.4. Strategic initiatives
CHAPTER 10. CONCLUSION
LIST OF TABLES
Table 1 List of abbreviation
Table 2 North America drug testing market, by region, 2018 - 2030 (USD Million)
Table 3 North America drug testing market, by products, 2018 - 2030 (USD Million)
Table 4 North America drug testing market, by sample, 2018 - 2030 (USD Million)
Table 5 North America drug testing market, by drug, 2018 - 2030 (USD Million)
Table 6 North America drug testing market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. drug testing market, by products, 2018 - 2030 (USD Million)
Table 8 U.S. drug testing market, by sample, 2018 - 2030 (USD Million)
Table 9 U.S. drug testing market, by drug, 2018 - 2030 (USD Million)
Table 10 U.S. drug testing market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada drug testing market, by products, 2018 - 2030 (USD Million)
Table 12 Canada drug testing market, by sample, 2018 - 2030 (USD Million)
Table 13 Canada drug testing market, by drug, 2018 - 2030 (USD Million)
Table 14 Canada drug testing market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe drug testing market, by region, 2018 - 2030 (USD Million)
Table 16 Europe drug testing market, by products, 2018 - 2030 (USD Million)
Table 17 Europe drug testing market, by sample, 2018 - 2030 (USD Million)
Table 18 Europe drug testing market, by drug, 2018 - 2030 (USD Million)
Table 19 Europe drug testing market, by end use, 2018 - 2030 (USD Million)
Table 20 Germany drug testing market, by products, 2018 - 2030 (USD Million)
Table 21 Germany drug testing market, by sample, 2018 - 2030 (USD Million)
Table 22 Germany drug testing market, by drug, 2018 - 2030 (USD Million)
Table 23 Germany drug testing market, by end use, 2018 - 2030 (USD Million)
Table 24 UK drug testing market, by products, 2018 - 2030 (USD Million)
Table 25 UK drug testing market, by sample, 2018 - 2030 (USD Million)
Table 26 UK drug testing market, by drug, 2018 - 2030 (USD Million)
Table 27 UK drug testing market, by end use, 2018 - 2030 (USD Million)
Table 28 France drug testing market, by products, 2018 - 2030 (USD Million)
Table 29 France drug testing market, by sample, 2018 - 2030 (USD Million)
Table 30 France drug testing market, by drug, 2018 - 2030 (USD Million)
Table 31 France drug testing market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy drug testing market, by products, 2018 - 2030 (USD Million)
Table 33 Italy drug testing market, by sample, 2018 - 2030 (USD Million)
Table 34 Italy drug testing market, by drug, 2018 - 2030 (USD Million)
Table 35 Italy drug testing market, by end use, 2018 - 2030 (USD Million)
Table 36 Spain drug testing market, by products, 2018 - 2030 (USD Million)
Table 37 Spain drug testing market, by sample, 2018 - 2030 (USD Million)
Table 38 Spain drug testing market, by drug, 2018 - 2030 (USD Million)
Table 39 Spain drug testing market, by end use, 2018 - 2030 (USD Million)
Table 40 Denmark drug testing market, by products, 2018 - 2030 (USD Million)
Table 41 Denmark drug testing market, by sample, 2018 - 2030 (USD Million)
Table 42 Denmark drug testing market, by drug, 2018 - 2030 (USD Million)
Table 43 Denmark drug testing market, by end use, 2018 - 2030 (USD Million)
Table 44 Sweden drug testing market, by products, 2018 - 2030 (USD Million)
Table 45 Sweden drug testing market, by sample, 2018 - 2030 (USD Million)
Table 46 Sweden drug testing market, by drug, 2018 - 2030 (USD Million)
Table 47 Sweden drug testing market, by end use, 2018 - 2030 (USD Million)
Table 48 Norway drug testing market, by products, 2018 - 2030 (USD Million)
Table 49 Norway drug testing market, by sample, 2018 - 2030 (USD Million)
Table 50 Norway drug testing market, by drug, 2018 - 2030 (USD Million)
Table 51 Norway drug testing market, by end use, 2018 - 2030 (USD Million)
Table 52 Asia Pacific drug testing market, by region, 2018 - 2030 (USD Million)
Table 53 Asia Pacific drug testing market, by products, 2018 - 2030 (USD Million)
Table 54 Asia Pacific drug testing market, by sample, 2018 - 2030 (USD Million)
Table 55 Asia Pacific drug testing market, by drug, 2018 - 2030 (USD Million)
Table 56 Asia Pacific drug testing market, by end use, 2018 - 2030 (USD Million)
Table 57 China drug testing market, by products, 2018 - 2030 (USD Million)
Table 58 China drug testing market, by sample, 2018 - 2030 (USD Million)
Table 59 China drug testing market, by drug, 2018 - 2030 (USD Million)
Table 60 China drug testing market, by end use, 2018 - 2030 (USD Million)
Table 61 Japan drug testing market, by products, 2018 - 2030 (USD Million)
Table 62 Japan drug testing market, by sample, 2018 - 2030 (USD Million)
Table 63 Japan drug testing market, by drug, 2018 - 2030 (USD Million)
Table 64 Japan drug testing market, by end use, 2018 - 2030 (USD Million)
Table 65 India drug testing market, by products, 2018 - 2030 (USD Million)
Table 66 India drug testing market, by sample, 2018 - 2030 (USD Million)
Table 67 India drug testing market, by drug, 2018 - 2030 (USD Million)
Table 68 India drug testing market, by end use, 2018 - 2030 (USD Million)
Table 69 South Korea drug testing market, by products, 2018 - 2030 (USD Million)
Table 70 South Korea drug testing market, by sample, 2018 - 2030 (USD Million)
Table 71 South Korea drug testing market, by drug, 2018 - 2030 (USD Million)
Table 72 South Korea drug testing market, by end use, 2018 - 2030 (USD Million)
Table 73 Australia drug testing market, by products, 2018 - 2030 (USD Million)
Table 74 Australia drug testing market, by sample, 2018 - 2030 (USD Million)
Table 75 Australia drug testing market, by drug, 2018 - 2030 (USD Million)
Table 76 Australia drug testing market, by end use, 2018 - 2030 (USD Million)
Table 77 Thailand drug testing market, by products, 2018 - 2030 (USD Million)
Table 78 Thailand drug testing market, by sample, 2018 - 2030 (USD Million)
Table 79 Thailand drug testing market, by drug, 2018 - 2030 (USD Million)
Table 80 Thailand drug testing market, by end use, 2018 - 2030 (USD Million)
Table 81 Latin America drug testing market, by products, 2018 - 2030 (USD Million)
Table 82 Latin America drug testing market, by sample, 2018 - 2030 (USD Million)
Table 83 Latin America drug testing market, by drug, 2018 - 2030 (USD Million)
Table 84 Latin America drug testing market, by end use, 2018 - 2030 (USD Million)
Table 85 Brazil drug testing market, by products, 2018 - 2030 (USD Million)
Table 86 Brazil drug testing market, by sample, 2018 - 2030 (USD Million)
Table 87 Brazil drug testing market, by drug, 2018 - 2030 (USD Million)
Table 88 Brazil drug testing market, by end use, 2018 - 2030 (USD Million)
Table 89 Mexico drug testing market, by products, 2018 - 2030 (USD Million)
Table 90 Mexico drug testing market, by sample, 2018 - 2030 (USD Million)
Table 91 Mexico drug testing market, by drug, 2018 - 2030 (USD Million)
Table 92 Mexico drug testing market, by end use, 2018 - 2030 (USD Million)
Table 93 Argentina drug testing market, by products, 2018 - 2030 (USD Million)
Table 94 Argentina drug testing market, by sample, 2018 - 2030 (USD Million)
Table 95 Argentina drug testing market, by drug, 2018 - 2030 (USD Million)
Table 96 Argentina drug testing market, by end use, 2018 - 2030 (USD Million)
Table 97 MEA drug testing market, by region, 2018 - 2030 (USD Million)
Table 98 MEA drug testing market, by products, 2018 - 2030 (USD Million)
Table 99 MEA drug testing market, by sample, 2018 - 2030 (USD Million)
Table 100 MEA drug testing market, by drug, 2018 - 2030 (USD Million)
Table 101 MEA drug testing market, by end use, 2018 - 2030 (USD Million)
Table 102 South Africa drug testing market, by products, 2018 - 2030 (USD Million)
Table 103 South Africa drug testing market, by sample, 2018 - 2030 (USD Million)
Table 104 South Africa drug testing market, by drug, 2018 - 2030 (USD Million)
Table 105 South Africa drug testing market, by end use, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia drug testing market, by products, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia drug testing market, by sample, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia drug testing market, by drug, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia drug testing market, by end use, 2018 - 2030 (USD Million)
Table 110 UAE drug testing market, by products, 2018 - 2030 (USD Million)
Table 111 UAE drug testing market, by sample, 2018 - 2030 (USD Million)
Table 112 UAE drug testing market, by drug, 2018 - 2030 (USD Million)
Table 113 UAE drug testing market, by end use, 2018 - 2030 (USD Million)
Table 114 Kuwait drug testing market, by products, 2018 - 2030 (USD Million)
Table 115 Kuwait drug testing market, by sample, 2018 - 2030 (USD Million)
Table 116 Kuwait drug testing market, by drug, 2018 - 2030 (USD Million)
Table 117 Kuwait drug testing market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 North America drug testing market, by region, 2018 - 2030 (USD Million)
Table 3 North America drug testing market, by products, 2018 - 2030 (USD Million)
Table 4 North America drug testing market, by sample, 2018 - 2030 (USD Million)
Table 5 North America drug testing market, by drug, 2018 - 2030 (USD Million)
Table 6 North America drug testing market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. drug testing market, by products, 2018 - 2030 (USD Million)
Table 8 U.S. drug testing market, by sample, 2018 - 2030 (USD Million)
Table 9 U.S. drug testing market, by drug, 2018 - 2030 (USD Million)
Table 10 U.S. drug testing market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada drug testing market, by products, 2018 - 2030 (USD Million)
Table 12 Canada drug testing market, by sample, 2018 - 2030 (USD Million)
Table 13 Canada drug testing market, by drug, 2018 - 2030 (USD Million)
Table 14 Canada drug testing market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe drug testing market, by region, 2018 - 2030 (USD Million)
Table 16 Europe drug testing market, by products, 2018 - 2030 (USD Million)
Table 17 Europe drug testing market, by sample, 2018 - 2030 (USD Million)
Table 18 Europe drug testing market, by drug, 2018 - 2030 (USD Million)
Table 19 Europe drug testing market, by end use, 2018 - 2030 (USD Million)
Table 20 Germany drug testing market, by products, 2018 - 2030 (USD Million)
Table 21 Germany drug testing market, by sample, 2018 - 2030 (USD Million)
Table 22 Germany drug testing market, by drug, 2018 - 2030 (USD Million)
Table 23 Germany drug testing market, by end use, 2018 - 2030 (USD Million)
Table 24 UK drug testing market, by products, 2018 - 2030 (USD Million)
Table 25 UK drug testing market, by sample, 2018 - 2030 (USD Million)
Table 26 UK drug testing market, by drug, 2018 - 2030 (USD Million)
Table 27 UK drug testing market, by end use, 2018 - 2030 (USD Million)
Table 28 France drug testing market, by products, 2018 - 2030 (USD Million)
Table 29 France drug testing market, by sample, 2018 - 2030 (USD Million)
Table 30 France drug testing market, by drug, 2018 - 2030 (USD Million)
Table 31 France drug testing market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy drug testing market, by products, 2018 - 2030 (USD Million)
Table 33 Italy drug testing market, by sample, 2018 - 2030 (USD Million)
Table 34 Italy drug testing market, by drug, 2018 - 2030 (USD Million)
Table 35 Italy drug testing market, by end use, 2018 - 2030 (USD Million)
Table 36 Spain drug testing market, by products, 2018 - 2030 (USD Million)
Table 37 Spain drug testing market, by sample, 2018 - 2030 (USD Million)
Table 38 Spain drug testing market, by drug, 2018 - 2030 (USD Million)
Table 39 Spain drug testing market, by end use, 2018 - 2030 (USD Million)
Table 40 Denmark drug testing market, by products, 2018 - 2030 (USD Million)
Table 41 Denmark drug testing market, by sample, 2018 - 2030 (USD Million)
Table 42 Denmark drug testing market, by drug, 2018 - 2030 (USD Million)
Table 43 Denmark drug testing market, by end use, 2018 - 2030 (USD Million)
Table 44 Sweden drug testing market, by products, 2018 - 2030 (USD Million)
Table 45 Sweden drug testing market, by sample, 2018 - 2030 (USD Million)
Table 46 Sweden drug testing market, by drug, 2018 - 2030 (USD Million)
Table 47 Sweden drug testing market, by end use, 2018 - 2030 (USD Million)
Table 48 Norway drug testing market, by products, 2018 - 2030 (USD Million)
Table 49 Norway drug testing market, by sample, 2018 - 2030 (USD Million)
Table 50 Norway drug testing market, by drug, 2018 - 2030 (USD Million)
Table 51 Norway drug testing market, by end use, 2018 - 2030 (USD Million)
Table 52 Asia Pacific drug testing market, by region, 2018 - 2030 (USD Million)
Table 53 Asia Pacific drug testing market, by products, 2018 - 2030 (USD Million)
Table 54 Asia Pacific drug testing market, by sample, 2018 - 2030 (USD Million)
Table 55 Asia Pacific drug testing market, by drug, 2018 - 2030 (USD Million)
Table 56 Asia Pacific drug testing market, by end use, 2018 - 2030 (USD Million)
Table 57 China drug testing market, by products, 2018 - 2030 (USD Million)
Table 58 China drug testing market, by sample, 2018 - 2030 (USD Million)
Table 59 China drug testing market, by drug, 2018 - 2030 (USD Million)
Table 60 China drug testing market, by end use, 2018 - 2030 (USD Million)
Table 61 Japan drug testing market, by products, 2018 - 2030 (USD Million)
Table 62 Japan drug testing market, by sample, 2018 - 2030 (USD Million)
Table 63 Japan drug testing market, by drug, 2018 - 2030 (USD Million)
Table 64 Japan drug testing market, by end use, 2018 - 2030 (USD Million)
Table 65 India drug testing market, by products, 2018 - 2030 (USD Million)
Table 66 India drug testing market, by sample, 2018 - 2030 (USD Million)
Table 67 India drug testing market, by drug, 2018 - 2030 (USD Million)
Table 68 India drug testing market, by end use, 2018 - 2030 (USD Million)
Table 69 South Korea drug testing market, by products, 2018 - 2030 (USD Million)
Table 70 South Korea drug testing market, by sample, 2018 - 2030 (USD Million)
Table 71 South Korea drug testing market, by drug, 2018 - 2030 (USD Million)
Table 72 South Korea drug testing market, by end use, 2018 - 2030 (USD Million)
Table 73 Australia drug testing market, by products, 2018 - 2030 (USD Million)
Table 74 Australia drug testing market, by sample, 2018 - 2030 (USD Million)
Table 75 Australia drug testing market, by drug, 2018 - 2030 (USD Million)
Table 76 Australia drug testing market, by end use, 2018 - 2030 (USD Million)
Table 77 Thailand drug testing market, by products, 2018 - 2030 (USD Million)
Table 78 Thailand drug testing market, by sample, 2018 - 2030 (USD Million)
Table 79 Thailand drug testing market, by drug, 2018 - 2030 (USD Million)
Table 80 Thailand drug testing market, by end use, 2018 - 2030 (USD Million)
Table 81 Latin America drug testing market, by products, 2018 - 2030 (USD Million)
Table 82 Latin America drug testing market, by sample, 2018 - 2030 (USD Million)
Table 83 Latin America drug testing market, by drug, 2018 - 2030 (USD Million)
Table 84 Latin America drug testing market, by end use, 2018 - 2030 (USD Million)
Table 85 Brazil drug testing market, by products, 2018 - 2030 (USD Million)
Table 86 Brazil drug testing market, by sample, 2018 - 2030 (USD Million)
Table 87 Brazil drug testing market, by drug, 2018 - 2030 (USD Million)
Table 88 Brazil drug testing market, by end use, 2018 - 2030 (USD Million)
Table 89 Mexico drug testing market, by products, 2018 - 2030 (USD Million)
Table 90 Mexico drug testing market, by sample, 2018 - 2030 (USD Million)
Table 91 Mexico drug testing market, by drug, 2018 - 2030 (USD Million)
Table 92 Mexico drug testing market, by end use, 2018 - 2030 (USD Million)
Table 93 Argentina drug testing market, by products, 2018 - 2030 (USD Million)
Table 94 Argentina drug testing market, by sample, 2018 - 2030 (USD Million)
Table 95 Argentina drug testing market, by drug, 2018 - 2030 (USD Million)
Table 96 Argentina drug testing market, by end use, 2018 - 2030 (USD Million)
Table 97 MEA drug testing market, by region, 2018 - 2030 (USD Million)
Table 98 MEA drug testing market, by products, 2018 - 2030 (USD Million)
Table 99 MEA drug testing market, by sample, 2018 - 2030 (USD Million)
Table 100 MEA drug testing market, by drug, 2018 - 2030 (USD Million)
Table 101 MEA drug testing market, by end use, 2018 - 2030 (USD Million)
Table 102 South Africa drug testing market, by products, 2018 - 2030 (USD Million)
Table 103 South Africa drug testing market, by sample, 2018 - 2030 (USD Million)
Table 104 South Africa drug testing market, by drug, 2018 - 2030 (USD Million)
Table 105 South Africa drug testing market, by end use, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia drug testing market, by products, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia drug testing market, by sample, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia drug testing market, by drug, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia drug testing market, by end use, 2018 - 2030 (USD Million)
Table 110 UAE drug testing market, by products, 2018 - 2030 (USD Million)
Table 111 UAE drug testing market, by sample, 2018 - 2030 (USD Million)
Table 112 UAE drug testing market, by drug, 2018 - 2030 (USD Million)
Table 113 UAE drug testing market, by end use, 2018 - 2030 (USD Million)
Table 114 Kuwait drug testing market, by products, 2018 - 2030 (USD Million)
Table 115 Kuwait drug testing market, by sample, 2018 - 2030 (USD Million)
Table 116 Kuwait drug testing market, by drug, 2018 - 2030 (USD Million)
Table 117 Kuwait drug testing market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Blood cancer diagnostics market: market outlook
Fig. 14 Blood cancer diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Blood cancer diagnostics market driver impact
Fig. 20 Blood cancer diagnostics market restraint impact
Fig. 21 Blood cancer diagnostics market strategic initiatives analysis
Fig. 22 Blood cancer diagnostics market: Product movement analysis
Fig. 23 Blood cancer diagnostics market: Product outlook and key takeaways
Fig. 24 Instruments estimates and forecast, 2018 - 2030
Fig. 25 Assay kits and reagents market estimates and forecast, 2018 - 2030
Fig. 26 Blood cancer diagnostics Market: Test movement analysis
Fig. 27 Blood cancer diagnostics market: Test outlook and key takeaways
Fig. 28 Blood tests market estimates and forecasts, 2018 - 2030
Fig. 29 Imaging tests market estimates and forecasts,2018 - 2030
Fig. 30 Biopsy market estimates and forecasts,2018 - 2030
Fig. 31 Molecular tests market estimates and forecasts,2018 - 2030
Fig. 32 Blood cancer diagnostics market: end use movement analysis
Fig. 33 Blood cancer diagnostics market: end use outlook and key takeaways
Fig. 34 Hospitals and clinics market estimates and forecasts, 2018 - 2030
Fig. 35 Diagnostic labs market estimates and forecasts,2018 - 2030
Fig. 36 Research institutes market estimates and forecasts, 2018 - 2030
Fig. 37 Global blood cancer diagnostics market: Regional movement analysis
Fig. 38 Global blood cancer diagnostics market: Regional outlook and key takeaways
Fig. 39 Global blood cancer diagnostics market share and leading players
Fig. 40 North America market share and leading players
Fig. 41 Europe market share and leading players
Fig. 42 Asia Pacific market share and leading players
Fig. 43 Latin America market share and leading players
Fig. 44 Middle East & Africa market share and leading players
Fig. 45 North America, by country
Fig. 46 North America
Fig. 47 North America market estimates and forecasts, 2018 - 2030
Fig. 48 U.S. key country dynamics
Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
Fig. 50 Canada country dynamics
Fig. 51 Canada market estimates and forecasts, 2018 - 2030
Fig. 52 Mexico country dynamics
Fig. 53 Mexico market estimates and forecasts, 2018 - 2030
Fig. 54 Europe
Fig. 55 Europe market estimates and forecasts, 2018 - 2030
Fig. 56 UK country dynamics
Fig. 57 UK market estimates and forecasts, 2018 - 2030
Fig. 58 Germany
Fig. 59 Germany market estimates and forecasts, 2018 - 2030
Fig. 60 France country dynamics
Fig. 61 France market estimates and forecasts, 2018 - 2030
Fig. 62 Italy country dynamics
Fig. 63 Italy market estimates and forecasts, 2018 - 2030
Fig. 64 Spain country dynamics
Fig. 65 Spain market estimates and forecasts, 2018 - 2030
Fig. 66 Denmark country dynamics
Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
Fig. 68 Sweden country dynamics
Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
Fig. 70 Norway country dynamics
Fig. 71 Norway market estimates and forecasts, 2018 - 2030
Fig. 72 Asia Pacific
Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 74 China country dynamics
Fig. 75 China market estimates and forecasts, 2018 - 2030
Fig. 76 Japan country dynamics
Fig. 77 Japan market estimates and forecasts, 2018 - 2030
Fig. 78 India country dynamics
Fig. 79 India market estimates and forecasts, 2018 - 2030
Fig. 80 Thailand country dynamics
Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
Fig. 82 South Korea country dynamics
Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
Fig. 84 Australia country dynamics
Fig. 85 Australia market estimates and forecasts, 2018 - 2030
Fig. 86 Latin America
Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
Fig. 88 Brazil country dynamics
Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
Fig. 90 Argentina country dynamics
Fig. 91 Argentina market estimates and forecasts, 2018 - 2030
Fig. 92 Middle East and Africa
Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 94 South Africa country dynamics
Fig. 95 South Africa market estimates and forecasts, 2018 - 2030
Fig. 96 Saudi Arabia country dynamics
Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 98 UAE country dynamics
Fig. 99 UAE market estimates and forecasts, 2018 - 2030
Fig. 100 Kuwait country dynamics
Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 102 Market share of key market players- Blood cancer diagnostics market, 2023
Fig. 103 Company Categorization
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Blood cancer diagnostics market: market outlook
Fig. 14 Blood cancer diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Blood cancer diagnostics market driver impact
Fig. 20 Blood cancer diagnostics market restraint impact
Fig. 21 Blood cancer diagnostics market strategic initiatives analysis
Fig. 22 Blood cancer diagnostics market: Product movement analysis
Fig. 23 Blood cancer diagnostics market: Product outlook and key takeaways
Fig. 24 Instruments estimates and forecast, 2018 - 2030
Fig. 25 Assay kits and reagents market estimates and forecast, 2018 - 2030
Fig. 26 Blood cancer diagnostics Market: Test movement analysis
Fig. 27 Blood cancer diagnostics market: Test outlook and key takeaways
Fig. 28 Blood tests market estimates and forecasts, 2018 - 2030
Fig. 29 Imaging tests market estimates and forecasts,2018 - 2030
Fig. 30 Biopsy market estimates and forecasts,2018 - 2030
Fig. 31 Molecular tests market estimates and forecasts,2018 - 2030
Fig. 32 Blood cancer diagnostics market: end use movement analysis
Fig. 33 Blood cancer diagnostics market: end use outlook and key takeaways
Fig. 34 Hospitals and clinics market estimates and forecasts, 2018 - 2030
Fig. 35 Diagnostic labs market estimates and forecasts,2018 - 2030
Fig. 36 Research institutes market estimates and forecasts, 2018 - 2030
Fig. 37 Global blood cancer diagnostics market: Regional movement analysis
Fig. 38 Global blood cancer diagnostics market: Regional outlook and key takeaways
Fig. 39 Global blood cancer diagnostics market share and leading players
Fig. 40 North America market share and leading players
Fig. 41 Europe market share and leading players
Fig. 42 Asia Pacific market share and leading players
Fig. 43 Latin America market share and leading players
Fig. 44 Middle East & Africa market share and leading players
Fig. 45 North America, by country
Fig. 46 North America
Fig. 47 North America market estimates and forecasts, 2018 - 2030
Fig. 48 U.S. key country dynamics
Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
Fig. 50 Canada country dynamics
Fig. 51 Canada market estimates and forecasts, 2018 - 2030
Fig. 52 Mexico country dynamics
Fig. 53 Mexico market estimates and forecasts, 2018 - 2030
Fig. 54 Europe
Fig. 55 Europe market estimates and forecasts, 2018 - 2030
Fig. 56 UK country dynamics
Fig. 57 UK market estimates and forecasts, 2018 - 2030
Fig. 58 Germany
Fig. 59 Germany market estimates and forecasts, 2018 - 2030
Fig. 60 France country dynamics
Fig. 61 France market estimates and forecasts, 2018 - 2030
Fig. 62 Italy country dynamics
Fig. 63 Italy market estimates and forecasts, 2018 - 2030
Fig. 64 Spain country dynamics
Fig. 65 Spain market estimates and forecasts, 2018 - 2030
Fig. 66 Denmark country dynamics
Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
Fig. 68 Sweden country dynamics
Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
Fig. 70 Norway country dynamics
Fig. 71 Norway market estimates and forecasts, 2018 - 2030
Fig. 72 Asia Pacific
Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 74 China country dynamics
Fig. 75 China market estimates and forecasts, 2018 - 2030
Fig. 76 Japan country dynamics
Fig. 77 Japan market estimates and forecasts, 2018 - 2030
Fig. 78 India country dynamics
Fig. 79 India market estimates and forecasts, 2018 - 2030
Fig. 80 Thailand country dynamics
Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
Fig. 82 South Korea country dynamics
Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
Fig. 84 Australia country dynamics
Fig. 85 Australia market estimates and forecasts, 2018 - 2030
Fig. 86 Latin America
Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
Fig. 88 Brazil country dynamics
Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
Fig. 90 Argentina country dynamics
Fig. 91 Argentina market estimates and forecasts, 2018 - 2030
Fig. 92 Middle East and Africa
Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 94 South Africa country dynamics
Fig. 95 South Africa market estimates and forecasts, 2018 - 2030
Fig. 96 Saudi Arabia country dynamics
Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 98 UAE country dynamics
Fig. 99 UAE market estimates and forecasts, 2018 - 2030
Fig. 100 Kuwait country dynamics
Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 102 Market share of key market players- Blood cancer diagnostics market, 2023
Fig. 103 Company Categorization
